Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer von Guarneri, V, Fasching, P A, Fernández Abad, M, García-Saenz, J A, Schneeweiss, A, Colleoni, M, Petru, E, Costigan, T M, Caldwell, C W, Barriga, S, Hurvitz, S, Slamon, D

Volltext

breast cancer, early stage Interim results from neoMONARCH: A neoadjuvant phase II study of abemaciclib in postmenopausal women with HR + /HER2- breast cancer (BC) von Hurvitz, S., Abad, M.F., Rostorfer, R., Chan, D., Egle, D., Huang, C.-S., Barriga, S., Costigan, T.M., Caldwell, C.W., Schilder, J.M., Press, M.F., Slamon, D., Martin, M.

Volltext

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study von Saucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K., Duvvuru, Suman, Effron, Mark B.

Volltext

A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer von Beeram, M., Tolaney, S.M., Beck, J.T., Dickler, M.N., Conlin, A.K., Dees, C., Helsten, T.L., Conkling, P.R., Edenfield, W.J., Richards, D.A., Kambhampati, S.R.P., Costigan, T.M., Chan, E., Pant, S., Kalinsky, K., Burris, H.A., Becerra, C.H., Rexer, B.N., Puhalla, S.L., Goetz, M.P.

Volltext

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways von Braun, Oscar Ö., Angiolillo, Dominick J., Ferreiro, Jose L., Jakubowski, Joseph A., Winters, Kenneth J., Effron, Mark B., Duvvuru, Suman, Costigan, Timothy M., Sundseth, Scott S., Walker, Joseph R., Saucedo, Jorge F., Kleiman, Neal S., Varenhorst, Christoph

Volltext

Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke von Levine, Steven R, Brey, Robin L, Tilley, Barbara C, Thompson, J L P, Sacco, Ralph L, Sciacca, Robert R, Murphy, A, Lu, Yimeng, Costigan, Teresa M, Rhine, Candi, Levin, Bruce, Triplett, Douglas A, Mohr, J P

Volltext

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways von O. Ö. Braun, D. J. Angiolillo, J. L. Ferreiro, J. A. Jakubowski, K. J. Winters, M. B. Effron, S. Duvvuru, T. M. Costigan, S. Sundseth, J. R. Walker, J. F. Saucedo, N. S. Kleiman, C. Varenhorst

Volltext

Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways von Braun, Oscar, Angiolillo, D J, Ferreiro, J L, Jakubowski, J A, Winters, K J, Effron, M B, Duvvuru, S, Costigan, T M, Sundseth, S, Walker, J R, Saucedo, J F, Kleiman, N S, Varenhorst, C

Volltext

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer von Hurvitz, S, Martin, M, Fernández Abad, M, Chan, D, Rostorfer, R, Petru, E, Barriga, S, Costigan, TM, Caldwell, CW, Nguyen, T, Press, M, Slamon, D

Volltext

Abstract PD5-01: Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (... von Martin, M, Hurvitz, SA, Chan, D, Fernandez-Abad, M, Petru, E, Rostorfer, R, Guarneri, V, Huang, C-S, Press, MF, Costigan, TM, Caldwell, CW, Wijayawardana, S, Turner, PK, Barriga, S, Slamon, DJ

Volltext

Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel von A. L. Frelinger, A. D. Michelson, S. D. Wiviott, D. Trenk, F.-J. Neumann, D. L. Miller, J. A. Jakubowski, T. M. Costigan, C. H. McCabe, E. M. Antman, E. Braunwald

Volltext

Optimal second-order product probability bounds von Block, Henry W., Costigan, Timothy M., Sampson, Allan R.

Volltext

The Combined Use of Ibutilide as an Active Control With Intensive Electrocardiographic Sampling and Signal Averaging as a Sensitive Method to Assess the Effects of Tadalafil on the... von Beasley, Charles M., Mitchell, Malcolm I., Dmitrienko, Alex A., Emmick, Jeffrey T., Shen, Wei, Costigan, Timothy M., Bedding, Alun W., Turik, Michael A., Bakhtyari, Arash, Warner, Margaret R., Ruskin, Jeremy N., Cantilena, Louis R., Kloner, Robert A.

Volltext

Combination setwise-Bonferroni-type bounds von Costigan, Timothy M.

Volltext

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine von Powers, Scott W, Coffey, Christopher S, Chamberlin, Leigh A, Ecklund, Dixie J, Klingner, Elizabeth A, Yankey, Jon W, Korbee, Leslie L, Porter, Linda L, Hershey, Andrew D

Volltext

Retinal Effects of 6 Months of Daily Use of Tadalafil or Sildenafil von Cordell, William H, Maturi, Raj K, Costigan, Timothy M, Marmor, Michael F, Weleber, Richard G, Coupland, Stuart G, Danis, Ronald P, McGettigan, John W, Antoszyk, Andrew N, Klise, Suzanne, Sides, Gregory D

Volltext

Fairy Forts von Catháin, Mícheál Ó, Treacy, Pat, Costigan, M.

Volltext bestellen

Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery von Bartels, Karsten, Mayes, Lena M, Dingmann, Colleen, Bullard, Kenneth J, Hopfer, Christian J, Binswanger, Ingrid A

Volltext

Neonatal pain-related stress and NFKBIA genotype are associated with altered cortisol levels in preterm boys at school age von Grunau, Ruth E, Cepeda, Ivan L, Chau, Cecil M Y, Brummelte, Susanne, Weinberg, Joanne, Lavoie, Pascal M, Ladd, Mihoko, Hirschfeld, Aaron F, Russell, Evan, Koren, Gideon, Van Uum, Stan, Brant, Rollin, Turvey, Stuart E

Volltext

Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage von COSTIGAN, Michael, SCHOLZ, Joachim, WOOLF, Clifford J

Volltext